Prospective Hyperthermia Database in Cancer Patients (HT Register)
Prospektive Hyperthermie-Datenbank Bei Krebspatienten (HTRegister)
Pirus Ghadjar
1,000 participants
Nov 1, 2014
OBSERVATIONAL
Conditions
Summary
This monocentric study registry records all cancer patients at the Charité which are treated with hyperthermia to examine the therapeutic use of hyperthermia in cancer patients in the general application and to obtain an accurate risk-benefit balance After confinement in this database are the patients prospectively in order to complications, disease status and survival status tracked. Furthermore there is the possibility in the course of this study to an optional take part in translational accompanying research with the aim of prognostic factors for response to hyperthermia treatment.
Eligibility
Inclusion Criteria4
- Contrazeption with female patients at the capable of bearing children age
- Written agreement is present (DvH, ICH-GCP)
- Patients, who participate at the same time in a interventional study, can nevertheless in this register study participate if this none Exclusion criterion for the interventional study represents.
- With children must the treatment with one of the GPOH agreed Pattern take place
Exclusion Criteria1
- mental disease, what the proper study participation does not allow.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
* die Höhe der Temperatur im Zielgebiet (42,5 bis 43 °C), * die Dauer der Anwendung und * die simultane Therapie mit Chemo- und/oder Strahlentherapie
Locations(2)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05993910